Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Sep-24 5:42 PM View:  | Dyne Therapeutics, Inc. (DYN) | 04-Sep-24 | Purchase | 32,000 | $33.04 | $1,057,220.00 | 640% 5.0K to 37.0K | |
| 11-Aug-23 4:10 PM View: | Sigilon Therapeutics, Inc. (SGTX) | 11-Aug-23 | Disposition | 341 | -- | -- | (100%) 0.34K to 0 | |
| 10-Dec-20 6:15 PM View: | Sigilon Therapeutics, Inc. (SGTX) | 08-Dec-20 | Conversion | 4,444 | -- | -- | 100% 0 to 4.44K | |
| 26-Mar-20 7:31 PM View: | Repligen Corp. (RGEN) | 24-Mar-20 | Market Sale | 1,858 | $96.72 | $179,706.00 | (67%) 2.78K to 0.92K | (107%) |
| 20-Mar-20 4:25 PM View: | Repligen Corp. (RGEN) | 18-Mar-20 | Option Exercise | 26,736 | $24.37 | $651,603.00 | 961% 2.78K to 29.52K | |
| 20-Mar-20 4:25 PM View: | Repligen Corp. (RGEN) | 18-Mar-20 | Market Option Sale | 26,736 | $95.27 | $2,547,040.00 | (91%) 29.52K to 2.78K | (110%) |
| 05-Mar-20 5:52 PM View: | Repligen Corp. (RGEN) | 04-Mar-20 | Option Exercise | 10,000 | $12.91 | $129,100.00 | 360% 2.78K to 12.78K | |
| 05-Mar-20 5:52 PM View: | Repligen Corp. (RGEN) | 04-Mar-20 | Market Option Sale | 10,000 | $93.39 | $933,900.00 | (78%) 12.78K to 2.78K | (114%) |
| 26-Feb-20 4:27 PM View: | Repligen Corp. (RGEN) | 24-Feb-20 | Market Sale | 4,455 | $92.81 | $413,455.00 | (62%) 7.24K to 2.78K | (115%) |
| 17-May-19 4:11 PM View: | Repligen Corp. (RGEN) | 15-May-19 | Grant | 923 | -- | -- | 15% 6.31K to 7.24K | |
| 17-May-18 4:43 PM View: | Repligen Corp. (RGEN) | 16-May-18 | Grant | 1,486 | -- | -- | 31% 4.83K to 6.31K | |
| 08-Mar-18 11:47 AM View: | Bioverativ Inc. (BIVV) | 08-Mar-18 | Disposition | 185,094 | -- | -- | (100%) 185.09K to 0 | |
| 26-Feb-18 5:11 PM View: | Bioverativ Inc. (BIVV) | 23-Feb-18 | Payment of Exercise | 5,794 | $104.74 | $606,864.00 | (3%) 190.89K to 185.09K | (< 1%) |
| 26-Feb-18 5:11 PM View: | Bioverativ Inc. (BIVV) | 22-Feb-18 | Payment of Exercise | 13,973 | $104.30 | $1,457,380.00 | (7%) 204.86K to 190.89K | (< 1%) |
| 15-Feb-18 5:04 PM View: | Bioverativ Inc. (BIVV) | 14-Feb-18 | Payment of Exercise | 10,819 | $103.52 | $1,119,980.00 | (5%) 215.68K to 204.86K | (1%) |
| 15-Feb-18 5:04 PM View: | Bioverativ Inc. (BIVV) | 14-Feb-18 | Option Exercise | 24,339 | -- | -- | 13% 191.34K to 215.68K | |
| 13-Feb-18 5:01 PM View: | Bioverativ Inc. (BIVV) | 11-Feb-18 | Payment of Exercise | 7,672 | $103.05 | $790,600.00 | (4%) 199.01K to 191.34K | (2%) |
| 13-Feb-18 5:01 PM View: | Bioverativ Inc. (BIVV) | 11-Feb-18 | Option Exercise | 18,381 | $9.53 | $175,171.00 | 10% 180.63K to 199.01K | |
| 22-May-17 5:01 PM View: | Repligen Corp. (RGEN) | 18-May-17 | Grant | 1,206 | -- | -- | 33% 3.62K to 4.83K | |
| 03-Apr-17 4:16 PM View: | Bioverativ Inc. (BIVV) | 31-Mar-17 | Payment of Exercise | 8,416 | $54.46 | $458,335.00 | (4%) 189.05K to 180.63K | (93%) |
| 02-Mar-17 4:08 PM View: | Bioverativ Inc. (BIVV) | 28-Feb-17 | Grant | 211,679 | -- | -- | 1384% 15.3K to 226.98K | |
| 02-Mar-17 4:08 PM View: | Bioverativ Inc. (BIVV) | 28-Feb-17 | Payment of Exercise | 37,931 | $46.09 | $1,748,140.00 | (17%) 226.98K to 189.05K | (128%) |
| 13-May-16 3:39 PM View: | Repligen Corp. (RGEN) | 11-May-16 | Grant | 1,763 | -- | -- | 95% 1.86K to 3.62K | |
| 05-Apr-16 5:04 PM View: | Biogen Idec Inc. (BIIB) | 01-Apr-16 | Grant | 8,444 | -- | -- | 28% 30.6K to 39.05K | |
| 25-Feb-16 5:04 PM View: | Biogen Idec Inc. (BIIB) | 23-Feb-16 | Payment of Exercise | 382 | $258.99 | $98,934.20 | (1%) 30.9K to 30.52K | (9%) |
| 25-Feb-16 5:04 PM View: | Biogen Idec Inc. (BIIB) | 23-Feb-16 | Option Exercise | 810 | -- | -- | 3% 30.09K to 30.9K | |
| 17-Feb-16 6:01 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-16 | Payment of Exercise | 1,552 | $247.22 | $383,685.00 | (5%) 31.64K to 30.09K | (14%) |
| 17-Feb-16 6:01 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-16 | Option Exercise | 3,298 | -- | -- | 12% 28.34K to 31.64K | |
| 09-Feb-16 4:51 PM View: | Biogen Idec Inc. (BIIB) | 08-Feb-16 | Payment of Exercise | 1,324 | $250.77 | $332,020.00 | (4%) 29.67K to 28.34K | (13%) |
| 09-Feb-16 4:51 PM View: | Biogen Idec Inc. (BIIB) | 08-Feb-16 | Option Exercise | 4,026 | -- | -- | 16% 25.64K to 29.67K | |
| 26-May-15 6:27 PM View: | Repligen Corp. (RGEN) | 21-May-15 | Grant | 1,858 | -- | -- | 100% 0 to 1.86K | |
| 26-Mar-15 4:31 PM View: | Biogen Idec Inc. (BIIB) | 25-Mar-15 | Option Exercise | 5,066 | $65.85 | $333,571.00 | 16% 32.51K to 37.58K | |
| 26-Mar-15 4:31 PM View: | Biogen Idec Inc. (BIIB) | 25-Mar-15 | Market Option Sale (Planned) | 5,066 | $449.06 | $2,274,940.00 | (13%) 37.58K to 32.51K | 37% |
| 26-Mar-15 4:31 PM View: | Biogen Idec Inc. (BIIB) | 25-Mar-15 | Market Sale (Planned) | 6,944 | $449.06 | $3,118,270.00 | (21%) 32.51K to 25.57K | 37% |
| 17-Feb-15 8:40 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-15 | Payment of Exercise | 1,761 | $392.11 | $690,506.00 | (5%) 34.27K to 32.51K | 28% |
| 17-Feb-15 8:40 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-15 | Option Exercise | 3,738 | -- | -- | 12% 30.53K to 34.27K | |
| 10-Feb-15 5:07 PM View: | Biogen Idec Inc. (BIIB) | 09-Feb-15 | Payment of Exercise | 2,210 | $396.88 | $877,105.00 | (7%) 32.74K to 30.53K | 29% |
| 10-Feb-15 5:07 PM View: | Biogen Idec Inc. (BIIB) | 09-Feb-15 | Option Exercise | 4,691 | -- | -- | 17% 28.05K to 32.74K | |
| 10-Feb-15 5:07 PM View: | Biogen Idec Inc. (BIIB) | 08-Feb-15 | Payment of Exercise | 1,537 | $402.00 | $617,874.00 | (5%) 29.59K to 28.05K | 30% |
| 10-Feb-15 5:07 PM View: | Biogen Idec Inc. (BIIB) | 08-Feb-15 | Option Exercise | 4,023 | -- | -- | 16% 25.57K to 29.59K | |
| 25-Feb-14 2:17 PM View: | Biogen Idec Inc. (BIIB) | 23-Feb-14 | Payment of Exercise | 1,228 | $347.11 | $426,251.00 | (5%) 26.71K to 25.48K | 19% |
| 25-Feb-14 2:17 PM View: | Biogen Idec Inc. (BIIB) | 23-Feb-14 | Option Exercise | 2,598 | -- | -- | 11% 24.11K to 26.71K | |
| 14-Feb-14 4:34 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-14 | Payment of Exercise | 1,059 | $323.04 | $342,099.00 | (4%) 25.17K to 24.11K | 13% |
| 14-Feb-14 4:34 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-14 | Option Exercise | 2,246 | -- | -- | 10% 22.92K to 25.17K | |
| 11-Feb-14 6:07 PM View: | Biogen Idec Inc. (BIIB) | 09-Feb-14 | Payment of Exercise | 2,212 | $315.54 | $697,974.00 | (9%) 25.13K to 22.92K | 10% |
| 11-Feb-14 6:07 PM View: | Biogen Idec Inc. (BIIB) | 09-Feb-14 | Option Exercise | 4,691 | -- | -- | 23% 20.44K to 25.13K | |
| 11-Feb-14 6:07 PM View: | Biogen Idec Inc. (BIIB) | 08-Feb-14 | Payment of Exercise | 1,441 | $315.54 | $454,693.00 | (7%) 21.88K to 20.44K | 10% |
| 11-Feb-14 6:07 PM View: | Biogen Idec Inc. (BIIB) | 08-Feb-14 | Option Exercise | 4,023 | -- | -- | 23% 17.86K to 21.88K | |
| 04-Dec-13 12:05 PM View: | Biogen Idec Inc. (BIIB) | 25-Nov-13 | Gift | 200 | -- | -- | (1%) 18.06K to 17.86K | |
| 07-May-13 1:33 PM View: | Biogen Idec Inc. (BIIB) | 03-May-13 | Payment of Exercise | 866 | $218.85 | $189,524.00 | (5%) 18.93K to 18.06K | (29%) |